Skip to content

GSK history

Every recorded change to GSK's data, most recent first.

  1. CurrentNext earnings date moved to Feb 3, 2027; next earnings date is now an estimate; the company overview was rewritten; the investment thesis was rewritten; the listed risks were updated; the balance sheet was rewritten; checkpoint passed: FDA decision on bepirovirsen for chronic hepatitis B; checkpoint passed: Q3 2026 results and Nuvalent accounting; checkpoint moved to Feb 3, 2027: Full-year 2026 results and 2027 guidance; recent events were updated.
  2. Next earnings date is now confirmed; the investment thesis was rewritten; checkpoint updated: Q3 2026 results and Nuvalent accounting; recent events were updated.
  3. This company was added.